Rating History for Axovant Gene Therapies (AXGT) by Baird

More Stocks Rated by Baird | Latest Ratings for AXGT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/12/2019 Brian Skorney Upgrade Outperform
(Neutral)		 13.00
(16.00)		 6.61
(2.10)		 -68.23% Details